Mocetinostat
2 Inquiries
726169-73-9
99%
2026-07-09
Coenzymes,Inhibito,Enzymes,Zymogens,Substrates,Native Microorganism Creatine Amidinohydrolase
-
Product Description
-
Seller Information
-
Inquiry History
-
Description
ProductName Mocetinostat Cat No CEI-0979 Description Mocetinostat selectively inhibits histone deacetylases (HDACs) 1-3 and 11 at submicromolar concentrations. It blocks cancer cell proliferation in vitro and has significant antitumor activity in vivo. Mocetinostat induces hyperacetylation of histones, causes expression of the tumor suppressor protein p21(WAF1/CIP1), and inhibits proliferation of human cancer cells growing in culture. Abbr Mocetinostat Appearance crystalline solid CAS No 726169-73-9 Molecular Weight 396.4 Da Purity >99% Stability Store at or below –20°C. Solid form is stable at least 12 months from date of receipt, when stored as directed. Do not store aqueous solutions for more than one day. Targets (HDACs) 1-3, 11 Molecular Formula C23H20N6O Solubility Soluble in DMSO category Inhibitors(c1514) cas_num 726169-73-9 Basic Info-
Product Name:
Mocetinostat
Other Name:Benzamide,N-(2-aminophenyl)-4-[[[4-(3-pyridinyl)-2-pyrimidinyl]amino]methyl]-;N-(2-Aminophenyl)-4-[[[4-(3-pyridinyl)-2-pyrimidinyl]amino]methyl]benzamide;MGCD 0103;Mocetinostat;MG 0103
CAS No.:726169-73-9
Molecular Formula:C23H20N6O
InChIKeys:InChIKey=HRNLUBSXIHFDHP-UHFFFAOYSA-N
Molecular Weight:396.452
Exact Mass:396.44
EC Number:232-668-6
UNII:A6GWB8T96J
DSSTox ID:DTXSID80222945
NCI Thesaurus Code:C62521
HScode:2933990090
Categories:
Characteristics-
PSA:
106
XLogP3:2.8
Density:1.3±0.1 g/cm3
Refractive Index:1.730
Hazard IdentificationClassification of the substance or mixture
no data available
GHS label elements, including precautionary statements
Pictogram(s) no data available Signal word no data available
Hazard statement(s) no data available
Precautionary statement(s) Prevention no data available
Response no data available
Storage no data available
Disposal no data available
Other hazards which do not result in classification
no data available
Handling and StoragePrecautions for safe handling
Handling in a well ventilated place. Wear suitable protective clothing. Avoid contact with skin and eyes. Avoid formation of dust and aerosols. Use non-sparking tools. Prevent fire caused by electrostatic discharge steam.
Conditions for safe storage, including any incompatibilities
Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials.
-
-
Seller Information
-
Business Type:
Manufactory
-
Main Products:
Coenzymes,Inhibito,Enzymes,Zymogens,Substrates,Native Microorganism Creatine Amidinohydrolase
-
Location:
Shirley, New York 11967, USA
-
Payment Terms:
TT against copy of documents,D/P
-
Average lead Time:
15
-
Total Annual Revenue:
$1 million-$2.5 million
-
Year of Establishment:
2004
-
-
Inquiry History2 Inquiries
Country Product Purchase Quantity Date Posted 
United States
Mocetinostat
2 G May 18, 2026
United States
Mocetinostat
2 G Mar 28, 2026 Post an enquiry for this product